Key facts
- It has raised $2.3M; the latest was Later Stage VC ($1.1M) in Jun 2025.
- Notable investors include Tech Incubator Program for Startup, Korea Technology Finance, DAYLI Partners, K-Startup Grand Challenge, POSTECH Holdings — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Lynk Solutec
- ·The full record, as it builds
Funding rounds
No funding rounds for Lynk Solutec are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Lynk Solutec
Developer of a nano-oil film coating designed to prevent the adhesion of blood, viruses, and bacteria. The company develops medical devices for safe and rapid patient treatment with an anti-fog and anti-blood endoscope cap to maintain the endoscope's field of view, enabling healthcare professionals with new products through research and development based on the inconvenience in the medical field.
- Sector
- Healthcare
- HQ
- Gimcheon, South Korea
- Founded
- 2020
- Employees
- 4
- Website
- lynksolutec.com/
- Ownership
- Privately Held (backing)
Lynk Solutec doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Lynk Solutec shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Lynk Solutec in its N-PORT filings yet. We sweep new filings monthly.